| Title | Intravitreal bevacizumab for myopic choroidal neovascularization: 1-year and 2-year results |
| Purpose | To report safety and efficacy results after 1 and 2 years of intravitreal bevacizumab injection (IVB) for active choroidal neovascularization associated with pathological myopia (mCNV). |
| Methods | For this retrospective interventional case series of 29 eyes, charts were reviewed of all patients who received IVB for active mCNV and who had a follow-up of at least 12 months after the first injection. Injections were repeated as needed, based on a decrease in best corrected visual acuity (BCVA), an increase in central macular thickness (CMT) of > 100 µm on optical coherence tomography (OCT), the recurrence of macular edema on OCT and/or leakage on fluorescein angiography. Patients were divided into 3 groups based on length of follow-up: patients in Group 1 had a follow-up of ≥12 months, in Group 2 of ≥18 months and in Group 3 of ≥24 months. Changes in visual acuity and CMT were analyzed, as were safety considerations. |
| Results | Twenty nine patients with a mean age of 62.2 years were included and 83 injections were administered. No ocular or systemic side effects were noted. Mean BCVA at baseline for all patients (n=29) was 20/100, at three months 20/80+ and at one year 20/63. At 18 months, Group 2 and 3 (n=19) had a mean BCVA of 20/80+. At 2 years, Group 3 (n=8) had a mean BCVA of 20/63. The BCVA had improved significantly at 3 months (p=0.0035) and one year (p=0.0042). Although BCVA gains were maintained at 18 and 24 months, these were not statistically significant (p=0.11 and p=0.19, respectively). The mean CMT decreased significantly at one year. |
| Conclusion | This study confirms that administration of intravitreal bevacizumab is a safe and effective treatment modality for mCNV. Statistically significant visual improvement can be obtained. |
| Last name | COPPENS |
| Initials | G |
| City | Leuven |
| Last name | Spielberg |
| Initials | L |
| City | Leuven |
| Last name | Leys |
| Initials | A |
| City | Leuven |